A relationship between resistance and dysregulation of the phosphatidylinositol 3-Kinase AKT (PI3K/AKT) pathway has been reported in several human cancers, including head and neck [89], breast [90], colon [91], bladder [92], and fibrosarcoma [93]. This evidence concerns the gene AKT1 and fibrosarcoma.